Actuate director granted 30,000 stock options
ACTUATE THERAPEUTICS, INC. director Dr. Martin H. Huber Jr. reported an initial holding of non-qualified stock options on Common Stock.
Rhea-AI Filing Summary
ACTUATE THERAPEUTICS, INC. director Dr. Martin H. Huber Jr. reported an initial holding of non-qualified stock options on Common Stock. He was granted 30,000 stock options upon joining the Board of Directors, with an exercise price of $3.00 per share and expiration on May 1, 2036.
The grant vests in three equal installments on the first, second, and third anniversaries of the grant date, contingent on his continued service. Following this grant, he holds derivative rights over 30,000 underlying shares through these options, representing equity-based compensation rather than an open-market trade.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Non-Qualified Stock Options | -- | -- | -- |
Footnotes (1)
- F1. 30,000 stock options were granted to Dr. Huber upon his appointment to the Board of Directors of Actuate Therapeutics, Inc., which option shall vest in three equal installments on the first, second, and third anniversary of the grant date, subject to the reporting person's continued service through each such vesting date.
Key Figures
Key Terms
Non-Qualified Stock Options financial
exercise price financial
vesting financial
Board of Directors financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider position is reported for ACTU director Martin H. Huber Jr. on this Form 3?
How many stock options did ACTU director Huber receive and at what exercise price?
What is the vesting schedule for the 30,000 ACTU stock options granted to Huber?
When do Dr. Huber’s ACTU stock options expire and what stock do they cover?
Does this ACTU Form 3 show any open-market buying or selling by Dr. Huber?
AI-generated analysis. How Rhea-AI works. Not financial advice.